Sanye Tablet Ameliorates Insulin Resistance and Dysregulated Lipid Metabolism in High-Fat Diet-Induced Obese Mice

• Main Authors: Minghe Yao (Author), Lin Li (Author), Ming Huang (Author), Yao Tan (Author), Ye Shang (Author), Xianghui Meng (Author), Yafen Pang (Author), Hong Xu (Author), Xin Zhao (Author), Wei Lei (Author), Yanxu Chang (Author), Yi Wang (Author), Deqin Zhang (Author), Boli Zhang (Author), Yuhong Li (Author)
• Format: Book
• Published: Frontiers Media S.A., 2021-09-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Sanye Tablet (SYT) is a patent prescription widely used in treating T2D and pre-diabetes, especially T2D comorbid with hypertriglyceridemia, for many years in China. However, the underlying mechanism that accounts for the anti-diabetic potential of SYT by regulating lipid-related intermediates remai...